Response to the Comment on "ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO-Metastatic Tumor Burden in the Future Liver Remnant for Decision-making of Staged Hepatectomy".

MLA

Hasselgren, Kristina, et al. “Response to the Comment on ‘ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO-Metastatic Tumor Burden in the Future Liver Remnant for Decision-Making of Staged Hepatectomy.’” Annals of Surgery, vol. 274, no. 6, Dec. 2021, pp. e750–51. EBSCOhost, https://doi.org/10.1097/SLA.0000000000004014.

APA

Hasselgren, K., Røsok, B. I., Larsen, P. N., Sparrelid, E., Lindell, G., Schultz, N. A., Bjørnbeth, B. A., Isaksson, B., Larsson, A. L., Rizell, M., Björnsson, B., & Sandström, P. (2021). Response to the Comment on “ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO-Metastatic Tumor Burden in the Future Liver Remnant for Decision-making of Staged Hepatectomy.” Annals of Surgery, 274(6), e750–e751. https://doi.org/10.1097/SLA.0000000000004014

Chicago

Hasselgren, Kristina, Bård I Røsok, Peter N Larsen, Ernesto Sparrelid, Gert Lindell, Nicolai A Schultz, Bjorn A Bjørnbeth, et al. 2021. “Response to the Comment on ‘ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO-Metastatic Tumor Burden in the Future Liver Remnant for Decision-Making of Staged Hepatectomy.’” Annals of Surgery 274 (6): e750–51. doi:10.1097/SLA.0000000000004014.